Topcon Healthcare’s Omnia Device Revolutionizes Eye Pre-Testing with FDA Clearance
The newly FDA-cleared Omnia device from Topcon Healthcare promises to significantly accelerate and streamline pre-testing procedures for optometrists and ophthalmologists, integrating four critical diagnostic tests into a single, automated platform.
Topcon Healthcare has announced the availability of Omnia, a groundbreaking device designed for fully automatic objective refraction, keratometry, tonometry, and pachymetry. The device, a cornerstone of Topcon’s “Healthcare from the Eye” initiative, aims to bring the power of artificial intelligence into routine eye care, enhancing efficiency and patient experience.
“in order for Healthcare from the Eye to reach its full potential, providers need access to high-quality devices that are reliable and easy to use and make capturing, analyzing and sharing data a smooth, secure and efficient process,” stated a senior official at Topcon Healthcare. “Omnia is the latest example of Topcon Healthcare’s commitment to delivering innovations that fulfill this promise and lay the foundation for the connected care ecosystem that we believe will ultimately transform the way health care is provided.”
The Omnia boasts a “fully automated, one-touch interface” with both automatic and manual alignment modes, simplifying operation for technicians. Its DICOM compatibility ensures seamless integration with existing electronic medical record (EMR) systems. Furthermore, the device incorporates advanced technology to minimize artifacts in fundus photography, utilizing a super luminescent diode for superior image quality compared to customary LED technology. Tonometry measurements are now delivered through a “quiet and softer air puff,” enhancing patient comfort. A rotating 360° screen provides flexibility in positioning for both patient and practitioner.
notably, the device requires “minimal training” for operation. Russell Gilliam,OD,of Eyecare Center of Martin in Tennessee,anticipates a positive impact on his team,stating he looks forward to seeing “the smiles on our techs’ faces when they see just how truly automated automation can be.”
According to a company release, Lance Patton, chief commercial officer of Topcon, emphasized the device’s responsiveness to market demand. “Omnia gives practices exactly what they’ve been asking for – fast, consistent measurements that streamline the entire pretest workflow,” patton said.”By combining four critical tests in one device, we’re helping clinics reduce bottlenecks, shorten chair time and elevate the patient experience.”
The device was cleared by the FDA and is now available for purchase.
Sources/Disclosures: Source: Press Release. A topcon Healthcare representative disclosed that Ali Tafreshi reports being CEO and president of Topcon Healthcare. Healio reported they could not confirm relevant financial disclosures for Dr. Gilliam at the time of publication.
